Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates

doi:10.3748/wjg.v24.i3.315

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 24, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8905)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

605

WORD

275

HTML

4550

Figures (1-1)

159

Tables (1-1)

149

Sum=5738

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

754

Download

546

Sum=1300

Publishing Process of This Article

Item

Count

Browse

985

Download

882

Sum=1867

Jan 21, 2018 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Jan 21, 2018; 24(3): 315-322
Published online Jan 21, 2018. doi: 10.3748/wjg.v24.i3.315

Open in New Tab Full Size Figure Download Figure

Figure 1 A pragmatic treatment approach in hepatitis C virus-infected liver transplant candidates. HCV: Hepatitis C virus; MELD: Model for End-Stage Liver Disease; LT: Liver transplantation; CTP: Child-Turcotte-Pugh; GFR: Glomerular filtration rate; LDLT: Living donor liver transplantation.

Citation: Gadiparthi C, Cholankeril G, Perumpail BJ, Yoo ER, Satapathy SK, Nair S, Ahmed A. Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates. World J Gastroenterol 2018; 24(3): 315-322
URL: https://www.wjgnet.com/1007-9327/full/v24/i3/315.htm
DOI: https://dx.doi.org/10.3748/wjg.v24.i3.315